EACH VIAL CONTAINS 10MG OF PT-141 (Bremelanotide)
Supplied for Research Purposes Only
This information and product is provided for research purposes only. We do not provide any advice on the usage of these products as UK Law prevents this. Customers should check the legality of this product in their own country prior to purchase.
Benefits and uses:
Enhancement of sexual desire as well as sexual performance.
The typical dosage is 1 mg, however the dosage can be increased to 4 milligrammes if the patient has a history of erectile dysfunction and medication has not been successful in treating it in the past.
Because different people have different reactions to Bremelanotide PT-141, the effective dosages may differ from person to person. In most cases, a dose of 2 mg, taken approximately one hour before sexual activity, is effective for both men and women. According to the findings of some studies, an initial test dose of 1 mg should be administered, followed by an injection of the same quantity 30 minutes later. During the course of research, some of the participants' responses to PT-141 took place within minutes, while others required several hours.
One dose should be taken every 24 hours, and you shouldn't take more than eight doses in a single month.
What is PT-141 (Bremelanotide)
PT-141 Bremelanotide is a modified synthetic derivative of alpha-melanocyte-stimulating hormone that is used to treat sexual dysfunction with viagra like performance in both men and women. Bremelanotide is a modified synthetic derivative of alpha-melanocyte-stimulating hormone.
It is believed that PT-141 is a good treatment for erectile dysfunction as well as enhanced libido in males, and it also has the potential to alleviate female sexual arousal problem in women.
Although PT-141 is presently employed in the treatment of sexual dysfunction in both men and women, this application for the drug was not its original intended usage. Melanotan II is a hormone that can cause skin pigmentation to become darker and can also encourage tanning. This hormone was used to generate the synthetic peptide blend.
Users of PT-141 are typically people who do not have a sexual desire or receptivity, who do not have the ability to become aroused, who have a lessened sensation, who have discomfort during intercourse, who are unable to attain an orgasm, or who have emotional concerns (shame, anxiety, embarrassment or reduced interest).
The mechanism of PT-141
Increased arousal, desire, and overall sexual satisfaction can be achieved with the help of PT 141, which acts on the neurological system directly.
PT-141 is a melanocortin receptor agonist that does not discriminate between which receptors it binds to. The PT-141 peptide therapy stimulates the dopamine hormones, which in turn improves sexual performance and heightens the desire to engage in sexual activity.
In some cases, the effects of PT-141 may become apparent within minutes, while in others, it may take several hours. The effects of the PT-141 therapy could potentially extend for up to twenty-four hours. Some men have reported that after taking PT-141, they experienced erections that lasted for up to two to six hours longer than usual.
PT-141 After eight weeks of treatment with bremelanotide, the medication should be discontinued if the patient does not experience an increase in sexual desire and the related distress.
Nausea and soreness at the injection site are the two negative effects of PT-141 that occur most frequently. Other potential adverse reactions include nausea and vomiting, flushing of the skin, impaired vision, headaches, dizziness, sluggish heart rate, anxiety, and pounding in the ears; however, these reactions are less likely to take place.
PT-141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction
P. B. MOLINOFF,A. M. SHADIACK,D. EARLE,L. E. DIAMOND,C. Y. QUON
First published: 24 January 2006 https://doi.org/10.1111/j.1749-6632.2003.tb03167.x